chr18-668465-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001071.4(TYMS):​c.455-607C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.126 in 152,128 control chromosomes in the GnomAD database, including 1,284 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.13 ( 1284 hom., cov: 32)

Consequence

TYMS
NM_001071.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.65

Publications

8 publications found
Variant links:
Genes affected
TYMS (HGNC:12441): (thymidylate synthetase) Thymidylate synthase catalyzes the methylation of deoxyuridylate to deoxythymidylate using, 10-methylenetetrahydrofolate (methylene-THF) as a cofactor. This function maintains the dTMP (thymidine-5-prime monophosphate) pool critical for DNA replication and repair. The enzyme has been of interest as a target for cancer chemotherapeutic agents. It is considered to be the primary site of action for 5-fluorouracil, 5-fluoro-2-prime-deoxyuridine, and some folate analogs. Expression of this gene and that of a naturally occurring antisense transcript, mitochondrial enolase superfamily member 1 (GeneID:55556), vary inversely when cell-growth progresses from late-log to plateau phase. Polymorphisms in this gene may be associated with etiology of neoplasia, including breast cancer, and response to chemotherapy. [provided by RefSeq, Aug 2017]
ENOSF1 (HGNC:30365): (enolase superfamily member 1) This gene can encode a mitochondrial enzyme that is thought to convert L-fuconate to 2-keto-3-deoxy-L-fuconate. This locus was originally identified as the source of antisense RNAs of the adjacent thymidylate synthase gene. Splice variants at this locus may contain an alternate 3' exon that is complementary to the 3'UTR and terminal intron of the thymidylate synthase (TS) RNA and may downregulate TS expression. [provided by RefSeq, Aug 2017]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.146 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001071.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TYMS
NM_001071.4
MANE Select
c.455-607C>T
intron
N/ANP_001062.1Q53Y97
TYMS
NM_001354867.2
c.455-2227C>T
intron
N/ANP_001341796.1P04818-2
TYMS
NM_001354868.2
c.206-607C>T
intron
N/ANP_001341797.1P04818-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TYMS
ENST00000323274.15
TSL:1 MANE Select
c.455-607C>T
intron
N/AENSP00000315644.10P04818-1
TYMS
ENST00000323224.7
TSL:1
c.455-2227C>T
intron
N/AENSP00000314727.7P04818-2
TYMS
ENST00000323250.9
TSL:1
c.206-607C>T
intron
N/AENSP00000314902.5P04818-3

Frequencies

GnomAD3 genomes
AF:
0.126
AC:
19082
AN:
152010
Hom.:
1280
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.119
Gnomad AMI
AF:
0.165
Gnomad AMR
AF:
0.0852
Gnomad ASJ
AF:
0.102
Gnomad EAS
AF:
0.00500
Gnomad SAS
AF:
0.0858
Gnomad FIN
AF:
0.146
Gnomad MID
AF:
0.123
Gnomad NFE
AF:
0.148
Gnomad OTH
AF:
0.122
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.126
AC:
19104
AN:
152128
Hom.:
1284
Cov.:
32
AF XY:
0.122
AC XY:
9107
AN XY:
74384
show subpopulations
African (AFR)
AF:
0.119
AC:
4944
AN:
41486
American (AMR)
AF:
0.0849
AC:
1298
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.102
AC:
353
AN:
3470
East Asian (EAS)
AF:
0.00502
AC:
26
AN:
5184
South Asian (SAS)
AF:
0.0863
AC:
416
AN:
4820
European-Finnish (FIN)
AF:
0.146
AC:
1547
AN:
10578
Middle Eastern (MID)
AF:
0.126
AC:
37
AN:
294
European-Non Finnish (NFE)
AF:
0.148
AC:
10068
AN:
67988
Other (OTH)
AF:
0.125
AC:
265
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
866
1732
2599
3465
4331
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
214
428
642
856
1070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.129
Hom.:
689
Bravo
AF:
0.121
Asia WGS
AF:
0.0510
AC:
176
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
0.61
DANN
Benign
0.74
PhyloP100
-1.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs16948305; hg19: chr18-668465; API